SCSC Form 4: Director Peter Browning Increases Stake to 29,593 Shares
Rhea-AI Filing Summary
Scansource director Peter C. Browning reported an acquisition of company stock on a Form 4. The filing states that on 09/01/2025 Mr. Browning acquired 3,693 shares of Common Stock (transaction code V) at a reported price of $0.00, bringing his beneficial ownership to 29,593 shares. The Form 4 is filed individually and was signed by an attorney-in-fact, J. Creighton Lynes, on 09/03/2025. The document provides no further context about the reason for the zero-price entry or the nature of the acquisition beyond the fields shown.
Positive
- Director acquired additional shares, increasing beneficial ownership to 29,593 shares
- Timely Form 4 filing provides transparency on insider activity with signature by attorney-in-fact
Negative
- None.
Insights
TL;DR: Routine director stock acquisition reported; limited material impact absent further context.
The Form 4 documents a non-derivative acquisition by a director, increasing reported beneficial ownership to 29,593 shares. As filed, the record shows transaction code "V" and a price of $0.00, but the filing does not explain the economic substance (e.g., gift, grant, or other). For governance review, this is a routine disclosure that provides transparency on insider holdings; however, without additional detail on the transaction type or size relative to outstanding shares, it is not by itself materially informative about corporate control or compensation policy.
TL;DR: Small insider acquisition disclosed; unlikely to change investor valuation by itself.
From a market perspective, the reported acquisition of 3,693 shares is modest in absolute terms. The filing confirms the director’s increased stake to 29,593 shares, but offers no pricing/consideration details beyond the listed $0.00. Because the filing lacks explanatory context and the position size is small relative to typical public-company float, this disclosure should be viewed as routine insider activity rather than a material signal.